Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
After FDA approval of enasidenib, a first-in-class drug targeting cancer metabolism via inhibition of IDH2 activity, more studies were conducted with R-2-HG positioned as an oncometabolite
Some provide lyophilized powder that you reconstitute yourself, while others ship pre-mixed solutions ready for injection
While a myriad of products promise transformative results, one often overlooked ally in the journey to healthy skin is L-Carnitine
Europe : Emerging Market with Growth Potential Europe GLP-1 Drug Market size was valued at USD 3.23 billion in 2024, making it the second-largest regional market with a 30% share
US$ 21.24
US$ 20.87
US$ 29.41
US$ 28.46
US$ 27.16
